{
  "ticker": "PEB",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968811",
  "id": "02968811",
  "pages": 10,
  "price_sensitive": true,
  "date": "20250714",
  "time": "0730",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrlhgrd1s0s7.pdf",
  "summary": "### **Capital Raising Announcement**  \n- **Structure**: Placement + Share Purchase Plan (SPP)  \n- **Placement**: AUD $16.1 million raised (oversubscribed) at $0.10/share (18% premium to 20-day VWAP).  \n- **SPP**: AUD $5 million targeted (potential oversubscription); retail shareholders eligible.  \n- **Key Dates**:  \n  - **Annual Meeting**: 6 August 2025 (shareholder approval for placement required).  \n  - **SPP Opening**: Mid-July 2025 (conditional on placement approval).  \n\n### **Operational Highlights (Q1 FY26)**  \n- **US Test Volumes**:  \n  - Total Laboratory Throughput (TLT): **6,900 tests** (down 8.9% QoQ).  \n  - US TLT: **5,717 tests** (down 11.9% QoQ) due to transition from *Detect* to *Triage*.  \n  - *Triage* adoption: **77% of US tests** in June 2025 (vs. 22% in Q4 FY25).  \n- **Asia Pacific Growth**: **1,183 tests** (up 8.8% QoQ).  \n- **Medicare Reconsideration**: Positive discussions with Novitas; reconsideration request submitted for *Triage* (based on AUA Guideline inclusion and STRATA study).  \n\n### **Material Developments**  \n1. **Triage Plus Progress**:  \n   - Analytical Validation published (Diagnostics, July 2025); supports Medicare reconsideration.  \n   - Draft Medicare price: **US$1,018/test** (vs. $760 for *Triage*). Pending DRIVE study peer review (submitted June 2025).  \n2. **AUA Guideline Impact**:  \n   - *Triage* holds \"Grade A\" evidence rating; drives payer negotiations (e.g., Optum VACCN coverage at Medicare rate).  \n3. **Cash Runway**: Capital raise extends runway **>12 months** without Medicare coverage.  \n\n---  \n**Omitted**: Routine details on director re-elections, clinical study timelines (non-near-term), and regional breakdowns.  \n**Key Focus**: Capital structure, volume trends, Medicare strategy, and *Triage Plus* commercialization.",
  "usage": {
    "prompt_tokens": 7214,
    "completion_tokens": 495,
    "total_tokens": 7709,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-13T22:10:10.943634"
}